핵의학

본문글자크기
  • [Breast Cancer Res Treat.] 유방암 림프부종에서 림프신티그라피의 예후예측능Predictive value of lymphoscintigraphy in patients with breast cancer-related lymphedema undergoing complex decongestive therapy.

    성균관의대 / 김영환, 최준영*

  • 출처
    Breast Cancer Res Treat.
  • 등재일
    2019 Feb
  • 저널이슈번호
    173(3):735-741. doi: 10.1007/s10549-018-5041-2. Epub 2018 Nov 12.
  • 내용

    바로가기  >

    그림1. 우측 상지 부종 환자로 우측 액와 림프절이 잘 관찰되고, 치료에 대한 반응이 우수하였음.

    그림2. 우측 상지 부종 환자로 우측 액와 림프절이 관찰되지 않았으며, 치료에 대한 반응이 좋지 않았음.

    Abstract
    PURPOSE:
    We evaluated the prognostic value of lymphoscintigraphy after complex decongestive therapy (CDT) in breast cancer-related secondary lymphedema.

    METHODS:
    Prior to CDT, 80 patients with breast cancer-related lymphedema underwent a 99mTc tin-colloid lymphoscintigram. We investigated the uptake patterns of axillary lymph nodes (LNs), main lymphatic vessels, collateral lymphatic vessels, and dermal back flow in the lymphoscintigraphy of the upper extremities. We also compared the above findings with other clinical variables between patients who respond well to CDT (responders) and those who do not (poor responders). We used Pearson's χ2 test and Fisher's exact test to compare the lymphoscintigram findings with the studied variables.

    RESULTS:
    There were 50 poor responders and 30 responders 1 year after CDT. There were significant differences between the two groups with regard to compliance (P < 0.05) and visualization of axillary LNs (P < 0.05). In combined results, the odds ratio was 21.33 (2.37-192.03) in the compliance and visible axillary LNs group compared to the poor compliance and invisible axillary LNs group.

    CONCLUSION:
    Lymphoscintigraphy of the upper extremities can be a useful tool to predict the prognosis of CDT in breast cancer-related lymphedema patients.

     


    Author information

    Kim YH1, Hwang JH2, Bae JH3, Choi JY4.
    1
    Department of Nuclear Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
    2
    Department of Physical & Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
    3
    Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
    4
    Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea. jynm.choi@samsung.com.

  • 키워드
    Breast cancer; Complex decongestive therapy; Lymphedema; Lymphoscintigraphy; Prognosis
  • 연구소개
    유방암과 연관된 림프부종 환자에 있어서 가장 일반적인 치료법인 복합물리치료(complex decongestive therapy) 전에 시행한 Tc-99m tin-colloid lymphoscintigraphy 영상소견이 치료 효과를 예측할 수 있다는 결과를 보인 연구 논문입니다. 복합물리치료 등의 림부부종 치료는 지속적이고 장기간의 치료가 필요한 것을 고려하면, 림프신티그라피에 의한 치료효과 예측은 환자들이 더 적극적으로 치료에 대한 순응을 유도할 수 있어, 임상적으로 중요한 결과입니다. 따라서, 재활의학과, 핵의학과 의사들 뿐 아니라 림프부종 환자들에게도 소개하고 및 도움이 될 만한 좋은 정보라 생각합니다.
  • 덧글달기
    덧글달기
       IP : 3.138.200.66

    등록